Member Info for RayPointer

Hello from Llan­fair­pwll­gwyn­gyll­gogery­chwyrn­drob­wlll­lanty­silio­gogo­goch!

Has the dump started yet?

Simple

It means the 99 bus is 9 minutes late and will arrive at 9:09

Possibly Trump will confuse the two, and proceed to hit Scancell with 100% tariffs 🤣

Still, it would be good publicity for Scancell.

Any truth in the rumour that his children are called Modi1, Modi2,.............. etc.

Well I sincerely hope that recent buyers are not hit too badly by the next placing

I suspect you will already have been filtered Luckybob 🤣

I think we have seen the gradual metamorphosis of Leon into a realist.

He has deleted the word "tremendous" from his vocabulary 🤣

Maybe too early to publish PFS data, but that would be interesting when it arrives and how it compares to SCIB1.

Hi Johnny

There's a blast from the past 🤣

Of course, the number of patients contributes to statistical significance, but that gap also contributes, as does the the time period.

"difference" and "care" 😂

Lets' see how the PFS in the Scope trial turns out for iSCIB1+ as time progresses.

It's off to a great start with a 22% different compared to current standard of card.

Hopefully, that 22% gap will get bigger

They are at a later stage than Scancell. So, it is worth keeping an eye on this to see whether the discussion with the FDA gets anywhere.

Are Val performing pre-clinical animal testing of CLX in combination with other treatments/drugs?

Do we expect Val to publish the results of such testing?

Rachel's surname wouldn't be Maxwell by any chance?

No doubt you are in the green bar, Rats.

Watch out for Mark, he may do a deal with you on your next pint.

There's a golden cross on the horizon.

I seem to remember it used to get somebody very excited 🤣

Hi WTP

*And is the assumption RE NDA's the correct one?"

I recall Scancell stating that NDAs were signed years ago when the results of the first SCIB1 trial were announced.

I wouldn't be surprised therefore, that NDAs have also been signed regarding the SCOPE trial.

I assume that, under an NDA, the pharma can ask further technical questions about the SCIB1 and iSCIB1+ products but only relating to the SCOPE data published so far.

If scinv were here he could probably confirm this or ridicule it

As at 31/03/2024 the average number of employees for the period was 0

as at 31/03/2025 the average number of employees for the period was 2

Apologies for getting the year incorrect in my previous post. They now have an average of 2 employees

https://find-and-update.company-information.service.gov.uk/company/14409383/filing-history

Lemons

I mention facts and you mention aspirations